XNK Therapeutics raised SEK 64 million
05 April 2021
05 April 2021
Total investments received (USD): 21.22m
Round value (USD): 7.49m
Company: XNK Therapeutics
Industry:
Biotech
Health services
Related deals
Intrance Medical Systems to raise $8 million from Swedish real estate investor Erik Selin Fastigheter AB.
Investments
20 September 2021
EnginZyme announced extending its series A funding round to €11 million.
Investments
11 February 2021
Sigrid Therapeutics in a new investment round.
Investments
11 December 2020
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom